CN Patent

CN113613654A — 治疗铁紊乱的组合物和方法

Assigned to BeyondSpring Pharmaceuticals Inc · Expires 2021-11-05 · 5y expired

What this patent protects

本文公开了在溶血导致血浆血红蛋白水平增加的情况下，减轻、预防或改善与血浆触珠蛋白消耗/减低相关的组织铁过剩和铁紊乱的方法。特别地，一些实施方案涉及将临床相关量的普那布林给予受试者。

USPTO Abstract

本文公开了在溶血导致血浆血红蛋白水平增加的情况下，减轻、预防或改善与血浆触珠蛋白消耗/减低相关的组织铁过剩和铁紊乱的方法。特别地，一些实施方案涉及将临床相关量的普那布林给予受试者。

Drugs covered by this patent

Patent Metadata

Patent number
CN113613654A
Jurisdiction
CN
Classification
—
Expires
2021-11-05
Drug substance claim
No
Drug product claim
No
Assignee
BeyondSpring Pharmaceuticals Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.